Paediatric and maternal schistosomiasis: shifting the paradigms.


Bustinduy, AL; Stothard, JR; Friedman, JF; (2017) Paediatric and maternal schistosomiasis: shifting the paradigms. British medical bulletin, 123 (1). pp. 115-125. ISSN 0007-1420 DOI: https://doi.org/10.1093/bmb/ldx028

This is the latest version of this item. Earlier version may have full text manuscript

[img]
Preview
Text - Accepted Version
License:

Download (614kB) | Preview

Abstract

In endemic areas, schistosomiasis causes both overt and subclinical disease in young children and their mothers, as well as in returned travellers. Key recently published literature. An action plan for paediatric schistosomiasis and female genital schistosomiasis (FGS) is needed with expanded access to praziquantel (PZQ) treatment required. Schistosomiasis-related morbidity is underappreciated. Present and future demand for PZQ treatment is bottlenecked, imbalanced and inequitable. Current dosing, treatment algorithms and access plans are suboptimal with treatment stalled during pregnancy. Raised dosing of PZQ (>40 mg/kg) is being explored in young children. Surveillance of female genital schistosomiasis FGS is increasing. Use of PZQ in pregnancy is safe and preventive chemotherapy guidelines are being revised in morbidity- and transmission-control settings. Shifting focus of population-level control to individual-case management. Detection and prevention of FGS within general health services and integration of PZQ treatment for women and children in antenatal clinics. Feasibility studies assessing alternative and expanded access to PZQ treatment to at-risk children and mothers and pregnant women.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID: 28910994
Web of Science ID: 412854400011
URI: http://researchonline.lshtm.ac.uk/id/eprint/4398435

Available Versions of this Item

Statistics


Download activity - last 12 months
Downloads since deposit
1Download
41Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item